What about the side-effects? Will I regain all my weight? Dr Sarah Jarvis has the answers to your burning questions.

The FDA has declared that the shortage of popular weight-loss drugs, including Ozempic and Wegovy, is officially over.

As a leading nutrition and longevity expert, I often see patients who want my advice on whether they should start taking ...

Consumers who use telehealth or medical spas to get less expensive, compounded weight loss drugs will need to get their ...

Ongoing trials of the next generation of weight loss drugs are revealing something unexpected: Some patients are losing too ...

Consumer Reports warns there are important considerations, especially for older adults, before starting these treatments.

The number of teens and young adults taking GLP-1 drugs has increased by 594 percent—but scientists are still trying to ...

Hims & Hers stock drops 26% as FDA resolves semaglutide shortage, threatening GLP-1 revenue. Click here to find out why HIMS ...

Weight loss medications like Wegovy and Zepbound are gaining popularity as millions turn to them for quick results and ...

The business of GLP-1s, it's mass adoption, compounded GLP-1s, compounding pharmacies, venture capital, and economic impact ...

The 35-year-old software developer, based in China's western metropolis of Chengdu, is about to start his third month on Ozempic, the brand name that pharmaceutical giant Novo Nordisk gives to ...

Hims & Hers plans to launch a generic version of liraglutide, but its efficacy is significantly lower than semaglutide. See ...